Illumina Reports Q4 2025 Revenue Of $1.155B, GAAP EPS $2.14–$2.17, Non-GAAP EPS $1.27–$1.30; FY2025 Revenue $4.34B, GAAP EPS $5.42–$5.45, Non-GAAP EPS $4.76–$4.79

Benzinga · Jan 13 22:12

Illumina, Inc. (NASDAQ:ILMN) ("Illumina" or the "company") today announced unaudited preliminary financial results for the fourth quarter and fiscal year 2025 ahead of its presentation at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time). The webcast can be accessed through Illumina's website at investor.illumina.com.

Preliminary fourth quarter 2025 results:

Revenue of approximately $1.155 billion, up 5% from Q4 2024 (up 4% on a constant currency basis)
Ex-China revenue of approximately $1.100 billion, up 7% from Q4 2024 (and on a constant currency basis)
GAAP diluted EPS of $2.14 to $2.17 and non-GAAP diluted EPS of $1.27 to $1.30

Preliminary...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.